PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $259,000 | +27.6% | 244,113 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $203,000 | -37.5% | 244,113 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $325,000 | -30.3% | 244,113 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $466,000 | -57.2% | 244,113 | 0.0% | 0.01% | -64.0% |
| Q1 2021 | $1,089,000 | +45.0% | 244,113 | +19.5% | 0.02% | -19.4% |
| Q3 2020 | $751,000 | +10.3% | 204,355 | +8.5% | 0.03% | +6.9% |
| Q2 2020 | $681,000 | – | 188,336 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,125,585 | $9,480,000 | 7.68% |
| DAFNA Capital Management LLC | 1,204,825 | $5,374,000 | 1.28% |
| Psagot Value Holdings Ltd. | 3,095,741 | $13,807,000 | 0.31% |
| Ground Swell Capital, LLC | 14,684 | $65,000 | 0.21% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 445,171 | $1,985,000,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,591 | $1,350,000 | 0.02% |
| Phoenix Holdings Ltd. | 244,113 | $1,089,000 | 0.02% |
| Virtu Financial LLC | 27,744 | $124,000 | 0.01% |
| D.A. DAVIDSON & CO. | 130,700 | $583,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 89,278 | $399,000 | 0.01% |